Interacting Drugs |
Etravirine vs Peginterferon Alfa-2b |
Security Level |
|
Mechanism |
Peginterferon Alfa-2b: May decrease the serum concentration of CYP2C9 Substrates (High risk). |
Management |
Monitor therapy |
Etravirine vs Peginterferon Alfa-2b
Post Review about Etravirine vs Peginterferon Alfa-2b Click here to cancel reply.
Other Interactions of Etravirine
Other Interactions of Peginterferon Alfa-2b
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.